Prediabetes Treatment & Medication

Prediabetes treatment is usually focused on lowering the risk of progressing to type 2 diabetes. For many people, that begins with evidence-based lifestyle changes, regular follow-up, and attention to related health risks such as blood pressure, cholesterol, and weight. Medication may be considered for some people at higher risk, but it is not automatically needed for everyone with prediabetes.

A healthcare provider can help build a prediabetes treatment plan based on your laboratory results, medical history, medications, risk factors, and goals.

How Is Prediabetes Usually Treated?

Prediabetes treatment commonly starts with lifestyle intervention and ongoing monitoring. The 2026 American Diabetes Association Standards recommend diabetes prevention programs for adults with overweight or obesity who are at high risk, with goals that include losing and maintaining at least 5% to 7% of initial body weight and getting at least 150 minutes of moderate-intensity physical activity per week. (Diabetes Journals)

Treatment may also include reviewing:

  • Eating habits and physical activity
  • Weight when clinically relevant
  • Blood pressure and cholesterol
  • Current medications
  • Family history
  • Previous A1C or glucose results
  • Other conditions that may affect diabetes risk

Prediabetes is associated with increased cardiovascular risk and often occurs alongside hypertension, abnormal cholesterol levels, and excess abdominal weight, so prevention may involve more than blood sugar alone. (Diabetes Journals)

For a broader overview, see Prediabetes Treatment & Prevention.

Can Lifestyle Changes Be Enough to Manage Prediabetes?

For many people, lifestyle changes are the main first-line approach to preventing or delaying type 2 diabetes.

CDC guidance recommends modest weight loss for people with overweight and regular physical activity. It describes a goal of about 5% to 7% weight loss and at least 150 minutes of moderate physical activity per week as part of evidence-based diabetes prevention. (CDC)

The original Diabetes Prevention Program found that an intensive lifestyle intervention reduced the risk of developing type 2 diabetes by 58% in the study population. That number reflects a research result and should not be interpreted as a guaranteed outcome for an individual patient. (CDC)

NIDDK also emphasizes healthy food choices, regular activity, weight management, and adequate sleep as part of improving insulin resistance and prediabetes. (NIDDK)

Whether lifestyle changes are enough depends on your overall risk, laboratory results, health conditions, and progress over time. Do I Need Medication for Prediabetes? explores that decision in more detail.

When Is Medication Considered for Prediabetes?

Prediabetes medication is not routine for every patient. The 2026 ADA Standards state that metformin should be considered for prevention of type 2 diabetes in adults at particularly high risk. (Diabetes Journals)

Medication decisions are individualized. A provider may consider factors such as how high the person’s A1C or fasting glucose is, age, body mass index, history of gestational diabetes, other medical conditions, and whether lifestyle intervention alone is meeting the patient’s prevention goals.

NIDDK also notes that healthcare professionals may prescribe medicines such as metformin in some cases to help manage blood glucose and reduce the chance of developing type 2 diabetes. (NIDDK)

This does not mean that an abnormal A1C automatically leads to a prescription. Medication should be discussed with a healthcare provider rather than started, stopped, or changed based on online information.

Las Caritas provides medication management in Garland, where medication questions and follow-up may be reviewed based on individual health needs. Provider review is required before medication changes or refills. (Site 3)

When Is Metformin Prescribed for Prediabetes?

Metformin has the strongest evidence among medications studied specifically for diabetes prevention in people with prediabetes.

The 2026 ADA Standards say metformin should be considered especially for adults at high risk, including people ages 25 to 59 with a BMI of 35 kg/m² or higher, fasting plasma glucose around 110 mg/dL or higher, A1C around 6.0% or higher, and people with a history of gestational diabetes. (DOI)

These factors are not a self-prescribing checklist. They describe groups in whom evidence suggests metformin may be especially useful. A clinician still needs to consider the patient’s complete medical history, other medications, potential side effects, and personal preferences.

The ADA also notes that metformin was less effective overall than intensive lifestyle intervention in the original Diabetes Prevention Program, although certain higher-risk groups benefited more substantially. (Diabetes Journals)

For a focused explanation, see When Is Metformin Prescribed for Prediabetes?

Who Is at Higher Risk of Progressing From Prediabetes to Type 2 Diabetes?

Not everyone with prediabetes has the same likelihood of progressing to diabetes.

The ADA identifies higher A1C and fasting glucose levels, obesity, family history, hypertension, abnormal lipid levels, physical inactivity, and previous gestational diabetes among factors associated with greater diabetes risk. (Diabetes Journals)

Within the prediabetes range itself, risk generally increases as blood glucose values move closer to the diabetes threshold. The ADA specifically highlights people with A1C above 6.0% and those with both impaired fasting glucose and impaired glucose tolerance as groups needing particularly vigilant follow-up. (Diabetes Journals)

A provider may therefore look at several factors together rather than judging risk from one A1C result.

Primary care can be useful for this broader assessment. Las Caritas’s chronic disease management in Garland includes review of blood sugar, blood pressure, cholesterol, medications, laboratory results, and follow-up needs as appropriate for the visit. (Site 3)

What Monitoring May Be Needed if Medication Is Used for Prediabetes?

Monitoring depends on the medication, how long it is used, other health conditions, and provider judgment.

For metformin, the 2026 ADA Standards recommend considering periodic vitamin B12 testing during long-term treatment, particularly in people with anemia or peripheral neuropathy. (DOI)

The FDA also recommends assessing kidney function before starting metformin and periodically during treatment because kidney function affects whether metformin can be used safely. (U.S. Food and Drug Administration)

Blood glucose monitoring also remains important. The ADA recommends checking people with prediabetes for progression to diabetes at least annually, with more frequent testing when individual risk warrants it. (DOI)

Monitoring may therefore include laboratory results, medication tolerance, side effects, changes in health, and progress toward prevention goals. Patients should report medication concerns rather than changing doses on their own.

How Does a Doctor Choose a Prediabetes Treatment Plan?

A prediabetes treatment plan should be individualized rather than based on one number.

A provider may consider:

  • A1C and fasting glucose trends
  • Age
  • Weight and BMI
  • Blood pressure and cholesterol
  • Family history
  • Previous gestational diabetes
  • Current medications
  • Other chronic conditions
  • Lifestyle habits and barriers
  • Patient preferences

NIDDK recommends a patient-centered approach to diabetes prevention that accounts for the person’s home, work, community, and ability to maintain changes over time. (NIDDK)

That means a useful plan should be realistic. A strategy that cannot be maintained may be less helpful than smaller changes that can become routine.

Medication is only one possible component. Lifestyle support, monitoring, cardiovascular risk reduction, and follow-up may all be part of the plan.

What Happens at a Doctor Visit for Prediabetes Treatment? explains what may be reviewed during an appointment.

When Should a Prediabetes Treatment Plan Be Reassessed?

A prediabetes treatment plan should be reassessed over time because blood sugar levels, medications, weight, lifestyle, and other health risks can change.

The 2026 ADA Standards recommend monitoring people with prediabetes for development of diabetes at least annually and adjusting testing frequency based on individual risk. (DOI)

A provider may recommend earlier reassessment if laboratory values are rising, new symptoms develop, medications change, weight changes significantly, or another health condition affects blood sugar.

Follow-up is also an opportunity to ask whether current goals remain realistic and whether additional support would help. Even when blood sugar improves, continued prevention efforts may still be worthwhile because future risk does not necessarily disappear.

Las Caritas provides primary care and family medicine that includes preventive care, chronic-care follow-up, lab review, and medication discussions based on the patient’s needs. (Site 3)

Want to Discuss Prediabetes Treatment Options With a Provider?

If you have prediabetes and are unsure whether lifestyle changes, medication discussions, or closer follow-up should be part of your plan, Las Caritas Walk In Clinic and Family Medicine provides primary care and chronic-care support in Garland, Texas.

Contact the clinic to ask about an appointment to discuss your health history, laboratory results, medications, risk factors, and possible next steps. Las Caritas does not guarantee metformin, another medication, testing, or any particular treatment plan.

Appointments are recommended for chronic-care visits. Walk-ins may be accepted based on availability, and same-day appointments may be available when scheduling permits.